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Abstract
Background: The prospect of eliminating onchocerciasis from Africa by mass treatment with ivermectin has been
rejuvenated following recent successes in foci in Mali, Nigeria and Senegal. Elimination prospects depend strongly on local
transmission conditions and therefore on pre-control infection levels. Pre-control infection levels in Africa have been
mapped largely by means of nodule palpation of adult males, a relatively crude method for detecting infection. We
investigated how informative pre-control nodule prevalence data are for estimating the pre-control prevalence of
microfilariae (mf) in the skin and discuss implications for assessing elimination prospects.
Methods and Findings: We analyzed published data on pre-control nodule prevalence in males aged $20 years and mf
prevalence in the population aged$5 years from 148 African villages. A meta-analysis was performed by means of Bayesian
hierarchical multivariate logistic regression, accounting for measurement error in mf and nodule prevalence, bioclimatic
zones, and other geographical variation. There was a strong positive correlation between nodule prevalence in adult males
and mf prevalence in the general population. In the forest-savanna mosaic area, the pattern in nodule and mf prevalence
differed significantly from that in the savanna or forest areas.
Significance: We provide a tool to convert pre-control nodule prevalence in adult males to mf prevalence in the general
population, allowing historical data to be interpreted in terms of elimination prospects and disease burden of
onchocerciasis. Furthermore, we identified significant geographical variation in mf prevalence and nodule prevalence
patterns warranting further investigation of geographical differences in transmission patterns of onchocerciasis.
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Introduction
In 1995, the World Health Organization launched the African
Programme for Onchocerciasis Control (APOC). At that time,
APOC aimed to control morbidity due to onchocerciasis (river
blindness) in Africa, with a focus on those countries not covered by
the previous Onchocerciasis Control Programme in West Africa
(OCP). Since 1995, APOC has successfully coordinated mass
treatment with ivermectin in sixteen onchocerciasis-endemic
African countries [1]. Until recently, elimination of onchocerciasis
from African foci was deemed to be not achievable by means of
mass ivermectin treatment alone, considering the large size of the
transmission zones, the mobility of the insect vectors and human
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populations, and poor compliance with mass treatment in some
areas [2]. However, following the first reports of elimination of
onchocerciasis from foci in Mali, Senegal, and Nigeria by mass
treatment alone [3,4,5], there is renewed interest in elimination of
onchocerciasis from Africa [6].
Pre-control infection levels are an important predictor of
morbidity levels [7,8,9] and the duration of onchocerciasis control
programs required to achieve elimination of infection [10,11].
High pre-control levels of infection indicate circumstances that are
favorable for intense transmission in terms of vector abundance,
proximity to vector breeding sites, high vectorial capacity and
competence, etc. In such circumstances, mass treatment with a
drug such as ivermectin, which is predominantly microfilaricidal,
but has a lesser impact on adult worm survival, needs to be
continued for a long time and at high therapeutic and
geographical coverage before it can be stopped without consid-
erable risk of recrudescence of infection. Progress towards
elimination of onchocerciasis from APOC areas is currently being
evaluated by means of ongoing skin snipping surveys that measure
levels of infection in terms of presence and density of microfilariae
(mf) in the skin of the general population [5]. In contrast, pre-
control levels of infection in APOC areas have been quantified by
the REMO method (rapid epidemiological mapping of onchocer-
ciasis), which is based on the palpation of subcutaneous nodules
containing adult Onchocerca volvulus worms in a sample of 30–50
males aged $20 years in villages selected using a standardized
selection procedure [12,13]. Results from pre-control and ongoing
surveys will have to be compared, even though the REMO
method is much cruder for detecting presence and intensity of
infection than skin snipping. Therefore, it is important to assess
how informative pre-control nodule palpation data are, and when
and whether they can be reliably translated to equivalent measures
of skin microfilariae. In other words, there is need for a
quantitative model describing the association between pre-control
nodule prevalence and pre-control presence of skin microfilariae,
which takes into account the differences between the two methods
as well as other covariates. Such a model would also allow
estimates of pre-control nodule prevalence to be related to the
large body of literature on the correlation between mf prevalence
and prevalence of onchocercal morbidity, allowing better estima-
tion of the disease burden of onchocerciasis.
We present a statistical model describing the association
between pre-control nodule prevalence in adult males and pre-
control mf prevalence in the general population. Quantitative
relationships for this association have been previously described,
but were based on smaller number of surveys, did not provide
estimates of uncertainty around parameter estimates and model
predictions, and did not account for geographical variation or the
relatively small sample sizes routinely used for the nodule
palpation method, resulting in attenuation bias (due to measure-
ment error in nodule prevalence) [14,15,16,17]. In this study, we
analyzed original pre-control data, accounting for these factors,
and using Bayesian statistical methods, well known for providing
robust uncertainty estimates around model parameters.
Methods
Data and Study Sites
We analyzed original data on pre-control nodule prevalence in
adult males (N = 7,525 individuals) and mf prevalence in the
population aged five years and above (N = 29,775 individuals)
from 148 villages in seven geographical areas including countries
in the former OCP area, and foci in Cameroon, Nigeria, and
Uganda, which are part of APOC (Table 1, Figure 1). Most of
these data have been previously published [9,14,18,19], except for
part of the data from Cameroon. The simuliid vectors responsible
for transmission in each area have been described previously
(Table 1) [9,19,20,21,22,23]. In all areas, data on nodule and mf
prevalence had been collected simultaneously (except for Nigeria,
where nodule palpation took place six to twelve months after skin
snipping, though still before the start of control interventions). All
data on mf prevalence were based on taking two skin snips (one
from each iliac crest) from each individual examined, which were
incubated in saline for 24 hours, and village-level prevalence
values were age- and sex-standardized according to the reference
OCP population (direct standardization, supplementary Table S1).
Then, we calculated the standardized number of mf positive
persons in a village by multiplying the standardized prevalence
with the sample size, and rounding to the nearest integer. Nodule
prevalence was based on palpation-based detection of nodules that
could be attributed to onchocerciasis with reasonable certainty,
similar to the methodology used for mapping of infection in
APOC areas; i.e. nodules of uncertain etiology (e.g. possible
enlarged lymph nodes) were excluded [12]. All data were used
with permission of the authors who originally collected such data,
and were analyzed anonymously.
Statistical Methods and Model Fitting
The association between village-level mf prevalence and nodule
prevalence was quantified in a meta-analysis by means of
hierarchical multivariate logistic regression, i.e. logistic regression
where the predicted outcome is a set of correlated binary random
variables rather than a single binary random variable. A
hierarchical approach was taken to account for unmeasured
sources of variation between geographical areas. A multivariate
approach was taken to account for measurement error in each
measure of infection. This approach prevents regression of model
coefficients towards zero (attenuation bias) as we do not have to
assume that there is no measurement error in the explanatory
variable (e.g. either nodule or mf prevalence), an assumption
inherent to univariate regression [24].
We extended the ordinary hierarchical logistic regression model
to a multivariate model simultaneously predicting m binary
Author Summary
Until recently, elimination of onchocerciasis (river blind-
ness) from Africa by mass treatment with ivermectin alone
was deemed impossible. However, recent reports of
elimination of onchocerciasis from various African foci
have stimulated renewed interest. An important determi-
nant of achieving elimination is the pre-control microfilar-
ial (mf) prevalence, i.e. the percentage of people with larval
stages of the Onchocerca volvulus worm in the skin, which
can be detected in a skin snip (a small skin biopsy).
Because this method is considered invasive, pre-control
infection levels in Africa have been mapped mostly by
means of palpation of subcutaneous nodules (protuber-
ances under the skin where the adult worms live) in adult
males, a relatively crude but non-invasive method of
detecting infection. We developed a tool to derive
estimates of pre-control mf prevalence from available
pre-control nodule prevalence estimates. This tool can
help evaluate ongoing control programs, help assess local
elimination prospects, and help estimate levels of disease
due to onchocerciasis by linking pre-control nodule
palpation data to the large body of literature on the
association between mf prevalence and disease.
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outcomes:
logit pij,m yij,m~kij,mDXij ,bm,nij,m
  
~XTij bmzeijzej ,
where pij,m is the probability of finding k cases of the m-th binary
outcome (m = 1: presence of microfilariae in the skin; m = 2:
presence of nodules in adult males) among nm observed individuals
from the i-th unit (village) and the j-th cluster (geographical area).
The error terms eij and ej (each consisting of m components)
represent the variation (random effects) in infection levels within
and between the j geographical areas, respectively. For each village
there is a set of observed covariates Xij , and for each of the m
predicted binary outcomes there is a set of parameters bm (fixed
effects), where the intercepts b0,m~1 and b0,m~2 represent the
mean log odds of presence of mf in the general population (all
those aged $5 years) and nodules in adult males. To explain
possible large differences between geographical areas related to
bioclime, parasite strains and clinical manifestations in onchocer-
ciasis [25], we included a set of coefficients for bioclimatic zone in
the model. Here, the parameters b1,m~1 and b1,m~2 represent the
log odds ratio of observing microfilariae in the skin and
subcutaneous nodules in forest areas (including degraded forest
and forest-savanna mosaic areas), relative to savanna areas.
Correlation between nodule and mf prevalence was modeled by
assuming a multivariate normal distribution for the m components
of the error term at each level of analysis. See supplementary Text
S1, section ‘‘Model description’’ for a more detailed description of
the model.
To account for measurement error due to misclassification of
nodules (e.g. classifying lymph nodes as onchocercal nodules due
to imperfect specificity; or failing to detect at least one
subcutaneous onchocercal nodule when one or more are present,
due to imperfect sensitivity), we added parameters to the model for
specificity and sensitivity of nodule palpation, allowing these to be
estimated from the data. Prior information for parameter values
was based on the literature. A wide range of values is reported for
specificity (60%–99%), based on various definitions [15,19,26,27].
We assumed that when performed by physicians experienced in
recognizing onchocercal nodules, specificity of nodule palpation is
between 98% and 100%, based on the report of finding only four
non-onchocercal nodules among 312 extirpated nodules [19].
Further, we assumed that sensitivity increases with level of
infection, reflecting the notion that detection of at least one
nodule is more likely in a person with many onchocercal nodules
than in a person with few or only one [27]. In literature, no values
for sensitivity of nodule palpation as a method for detecting
onchocercal nodules are reported. In the current study, sensitivity
was assumed to increase linearly from some unknown minimum
sensitivity (value between 60% and 100%) for nodule prevalences
close to zero (when persons with nodules have few nodules) to
100% for nodule prevalence of 100%. The choice of a linearly
increasing pattern was based on a simulation exercise in which we
examined the association between the proportion of the nodule
carriers that is detected and the ‘true’ nodule prevalence, given
simulated true nodule counts (assuming a negative binomial
distribution of counts within a village) and some probability to
detect each nodule (minimum sensitivity). A sensitivity analysis
showed that the model fit and model predictions did not change
when assuming different values for minimum sensitivity of nodule
palpation at low infection levels (60%, 80%, or 100%). This is
explained by the fact that sensitivity is most important for high
prevalence settings (for which we assume sensitivity is high
anyway), and far less important in low prevalence settings (where
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misclassification is largely governed by specificity). Therefore, we
simplified the final model by leaving out the parameter for
sensitivity, effectively assuming 100% sensitivity of nodule
palpation for all infection levels.
Based on the model described above, we estimated the
conditional distribution of mf prevalence in a hypothetical village
outside the dataset, given an estimate of the ‘true’ nodule
prevalence in adult males (i.e. corrected for misclassification of
nodules). We assumed that nodule prevalence estimates were
based on a sample of 30 adult males, the minimal sample size used
in REMO surveys [12,13]. See Text S1, section ‘‘Model
application’’ for a more detailed description of the methods for
predicting mf prevalences in hypothetical villages.
The model was fitted to the data in a Bayesian framework.
Posterior distributions of parameters and predictions were
simulated in JAGS (see Text S1, section ‘‘Model specification in
JAGS’’ for code), a program for analysis of Bayesian models using
Markov Chain Monte Carlo (MCMC) simulation based on the
Gibbs sampling algorithm (version 3.2.0; Martyn Plummer, 2012,
http://mcmc-jags.sourceforge.net). Simulations in JAGS were set
up and analyzed in R (version 2.14.2) [28], using packages rjags
(version 3–5, Martyn Plummer, 2011, http://CRAN.R-project.
org/package = rjags) and R2jags (version 0.03-06, Yu-Sung Su,
2011, http://CRAN.R-project.org/package = R2jags). Improve-
ments in model fit by addition of parameters were assessed via the
deviance information criterion (DIC), a generalization of Akaike’s
information criterion for hierarchical models (lower values indicate
better fit, taking into account model deviance and the effective
number of parameters in the model) [29]. See Text S1, section
‘‘Parameter estimation’’ for further details about model fitting and
checking of model convergence.
The final fit of the model to the data was evaluated by means of
mixed posterior predictive checks [30,31]. In this procedure, the
number of individuals positive for mf and nodules in each village
was resampled 40,000 times from the estimated joint posterior
distribution of model parameters, including resampling of all
Figure 1. Locations of study sites.
doi:10.1371/journal.pntd.0002168.g001
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random effects, and the resulting replicate dataset was compared
to the original data.
Results
The median nodule prevalence in males aged $20 years was
58% (range: 2%–100%), and the median mf prevalence in the
population aged five years and above was 74% (4%–99%). The
median sample size for nodule prevalence in a village was 42
(range: 9–181). The median sample size for mf prevalence in a
village was 167 (33–727).
Nodule prevalence in adult males was strongly positively
correlated with mf prevalence in the general population (Table
S2). There was significant geographical variation in patterns of
nodule and mf prevalence; in a model without any coefficients for
bioclime, the DIC increased from 1918 to 1920 when error term ej
was omitted. Point estimates of ej were very similar for savanna
and forest areas, with the exception of Mbam, Cameroon (forest-
savanna mosaic), for which mf prevalence was relatively high
compared to other areas. In line with this, the model fit did not
improve when a fixed effect parameter for bioclime was added to
the model. However, the model fit improved significantly when
Figure 2. Association between prevalence of nodules in adult males and skin mf in the general population. Colored symbols represent
data from seven geographical areas. Colored ellipses indicate the 95% percentiles (Z = 1.96) of the predicted joint distributions of infection
prevalences within each geographical area, based on the estimated variances and correlation of observations within geographical areas. Black
symbols represent the mean infection prevalences in each of the geographical areas. The black ellipse represents the 95% percentile of the joint
distribution of mean infection prevalences in geographical areas, illustrating the deviating pattern in nodule and mf prevalence in Mbam, Cameroon
(black and brown crosshairs and brown ellipse). Predictions were based on a Bayesian hierarchical multivariate logistic regression model with a fixed
effect for Mbam, Cameroon, and random effects for other geographical areas.
doi:10.1371/journal.pntd.0002168.g002
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modeling the difference between Mbam and all other areas as a
fixed effect (DIC 1913 vs. DIC 1918), indicating that mf
prevalences in Mbam were significantly higher than those in
other areas (Table S2, Figure 2). After this adaptation of the
model, there was still significant variation in patterns of nodule
and mf prevalence between geographical areas due to other,
unmeasured variables (the DIC increased to 1921 when error term
ej was omitted). Further, there was considerable uncertainty in the
Figure 3. Predicted skin mf prevalence in the general population, given observed nodule prevalence in adult males. Symbols
represent observed data by geographical area. Within each set of regression lines, the middle and outer lines relate to the median and 95% Bayesian
credible intervals of the posterior predictive distribution, respectively (black set for areas all areas but Mbam; grey set for Mbam, the only forest-
savanna mosaic area). Predictions were made assuming that nodule prevalence was based on a sample of 30 adult males.
doi:10.1371/journal.pntd.0002168.g003
Figure 4. Comparison of observations (x-axis) versus model predictions (y-axis). The comparison was made by means of mixed posterior
predictive checks of the numbers of individuals with detectable microfilariae in the skin and adult males with nodules. The dotted diagonal line
represents the hypothetical perfect model fit. Error bars represent the 95% Bayesian prediction interval for the numbers of adult males with nodules
and individuals with detectable microfilariae in the skin each village, and should intersect with the diagonal line if the model fit is good.
doi:10.1371/journal.pntd.0002168.g004
Onchocerciasis: Nodule and mf Prevalence
PLOS Neglected Tropical Diseases | www.plosntds.org 6 April 2013 | Volume 7 | Issue 4 | e2168
predictions for mf prevalence, based on nodule prevalence in a
sample of 30 males from a hypothetical village outside the dataset
(Figure 3).
Mixed posterior predictive checks showed that the model fitted
well to the data (Figure 4). Only three villages – all from different
regions, and all with relatively low infection levels compared to
other villages from the same region – deviated significantly from
the model predictions.
Discussion
We investigated the association between pre-control nodule
prevalence in adult males (aged $20 years) and pre-control mf
prevalence in the general population (aged $5 years). Our model
is the first to examine geographical variation due to bioclime and
other unmeasured variables, and to take account of measurement
error in nodule prevalence. Our results show that there is a strong
positive correlation between nodule and mf prevalence, but also
significant variation between geographical regions, which should
be taken into consideration when evaluating the prospects of
elimination and the burden of disease.
Our analysis showed significant geographical variation in
patterns of nodule and mf prevalence, though not related to
bioclimatic zones according to the classic forest vs. savanna
classification of onchocerciasis. In ‘forest’ areas – Lekie´, Cameroon
(degraded forest) and Kigoyera parish, Uganda (forest) – the
patterns in nodule and mf prevalences did not differ much from
the pattern in savanna areas. Yet, we found that mf prevalence
levels in the general population were relatively higher in the only
forest-savanna mosaic area (Mbam, Cameroon), while nodule
prevalence in adult males levels were not significantly different.
There are several possible explanations for this pattern. Most
likely, the pattern in Mbam is explained by a different pattern in
age-dependent exposure to black flies’ bites. Both mf and nodule
prevalences in individuals under the age of twenty years were
relatively high in Mbam compared to the other areas in
Cameroon, especially in villages with relatively low nodule
prevalence in adult males (data not shown). This indicates that
individuals in Mbam experience relatively high exposure levels at a
young age. This might be explained by the presence of dense forest
in this region with relatively few narrow open spaces, which is
associated with higher dispersal of flies around the breeding sites
[32]. Therefore, exposure may not be concentrated near the
breeding sites, but may extend over the whole village. Related to
this, exposure may be less concentrated in adults (who frequently
spent time near the breeding sites, forest galleries for fishing, etc.),
but may be more equally distributed over all age groups. However,
dense forest may not be unique for Mbam, and may also be
present in other forest areas in our data set. Therefore, we can
only say that it may be important to consider age-dependent
patterns in exposure to black flies’ bites and their effect on
transmission when translating nodule prevalence data to mf
prevalence. We rule out demography and survey methods, as all
mf prevalences were standardized, the mean age of the sampled
men from Mbam was similar to that of men from the other
Cameroonian areas, methods for skin snipping and mf enumer-
ation were the same as in other Cameroonian areas and, in
addition, even conducted by the same person (MB performed all
skin snipping in Faro, Lekie´, and Mbam, and 50% of skin snipping
in Vina valley). Furthermore, it is also unlikely that the forest sites
other than Mbam – Lekie´ and Kigoyera parish – harbor a savanna
parasite strain (instead of the assumed forest parasite strain) as this
is inconsistent with observed patterns of blindness in these areas
(forest pattern) [33,34]. Lastly, variation might have been caused
by parasite characteristics not related to the classic subdivision into
forest and savanna strains. Herder [35] concluded that the parasite
strains circulating in the Faro and Mbam areas were related but
distinct from the strains from Vina and Lekie´, based on
phylogenetic linkage patterns. However, this pattern was not
confirmed by our analysis as the association between nodule and
mf prevalence in Faro was very similar to the other areas but
Mbam.
Our model could be used as a tool for assessing the prospects of
elimination of onchocerciasis or the burden of onchocercal disease
when pre-control nodule prevalence in adult males is the only
measure of infection available (as is the case for most of Africa).
With our model, an estimate of pre-control mf prevalence may be
derived from pre-control nodule prevalence data. Such an
estimate may be helpful for program planning, providing an
indication of minimum program duration (with regard to
prospects of elimination), and could be helpful in the interpretation
of ongoing epidemiological parasitological surveys that rely on the
skin snipping method (in terms of progress towards elimination).
Prospects of elimination may be evaluated by comparing the
model-derived estimate of mf prevalence to known trends of
infection levels in other foci with a similar history of mass
treatment, or by means of dynamic modeling of the effect of mass
treatments with ivermectin using onchocerciasis transmission
models such as ONCHOSIM [10,11,36] and others [37,38,39].
Progress towards elimination could be evaluated by comparing
current mf prevalences with model-derived estimates of pre-
control mf prevalence and predicted trends in infection levels
based on dynamical modeling. Likewise, the pre-control burden of
ocular and dermal morbidity in endemic areas may be estimated
based on literature data on the association between mf and disease
prevalence [7,8,9]. This would further allow assessment of the
impact of control activities on population health, especially when
combined with aforementioned dynamic models. If pre-control mf
prevalence were to be severely underestimated or overestimated
when derived from nodule prevalence data (due to measurement
error and geographical variation), this may have important
repercussions for the number of treatment rounds that is thought
to be required to reach elimination, or the estimated burden of
disease. Therefore, it is crucial to consider variation due to sample
size and geographical variation in patterns of nodule and mf
prevalence when doing this kind of assessment. Given the high
level of variation and consequent uncertainty in the association
between nodule and mf prevalence, translations should be made
carefully and critically evaluated. We recommend that translations
of village-level REMO data (based on samples of about 30 adult
males) to mf prevalence are made based on the black lines in
Figure 3 (which include uncertainty due to measurement error and
geographical variation). In case of suspected high exposure of
children to flies’ bites, it may be more appropriate to apply the
part of the model that mimics the observations in Mbam,
Cameroon (grey lines in Figure 3). For areas where infection
prevalence is known to be homogeneously distributed, REMO
samples from multiple villages could be pooled into a more precise
estimate of pre-control nodule prevalence in the area, allowing
more precise prediction of the pre-control mf prevalence. In Text
S1, section ‘‘Model application’’, we explain in more detail how
our model should be applied to convert nodule prevalence to mf
prevalence (e.g. how to make predictions for a group of villages).
In conclusion, we provide a tool to convert nodule prevalence in
adult males to mf prevalence in the general population, which
accounts for uncertainty due to measurement error and geo-
graphical variation. This tool allows interpretation of a large
amount of pre-control data on levels of infection in Africa which
Onchocerciasis: Nodule and mf Prevalence
PLOS Neglected Tropical Diseases | www.plosntds.org 7 April 2013 | Volume 7 | Issue 4 | e2168
may a) be combined with information on coverage of mass
treatment to assess the feasibility of elimination of onchocerciasis
and b) enable estimation of disease burden. Furthermore, we
identified significant geographical variation in mf prevalence and
nodule prevalence patterns that warrants further investigation of
age-dependent transmission patterns of onchocerciasis.
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Table S1: Weights used to standardize prevalence of microfilariae in the skin. Standardization 
weights were based on the reference population of the Onchocerciasis Control Programme. 
Age Male Female 
5–9 0.091 0.078 
10–14 0.090 0.077 
15–29 0.129 0.138 
30–49 0.123 0.146 
≥ 50 0.063 0.064 
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Table S2. Model parameter estimates from Bayesian hierarchical multivariate logistic 
regression of infection prevalence data. The model predicts the joint distribution of prevalence of 
nodules in adult males (age ≥20) and presence of microfilariae (mf) in the skin of the general 
population (age ≥5). 
Parametera Interpretation Medianb Lower boundc 
Upper 
boundd 
 1,0-1logit m  Average fraction of general population with mf in the skin (excluding Mbam) 0.68 0.55 0.78 
 2,0-1logit m   Average fraction of adult males with onchocercal nodules (excluding Mbam) 0.51 0.36 0.67 
 1,1exp m  Odds ratio of presence of mf in the skin in Mbam compared to other areas 4.17 1.04 16.69 
 2,1exp m  Odds ratio of presence of nodules in Mbam compared to other areas 2.69 0.45 14.57 
1, mij  Standard deviation of log odds of presence of mf within geographical areas 0.98 0.87 1.11 
2, mij  Standard deviation of log odds of presence of nodules within geographical areas 0.89 0.77 1.03 
ij  Correlation of log odds of presence of nodules and mf within geographical areas 0.84 0.77 0.90 
1, mj  Standard deviation of average log odds of presence of mf between geographical areas 0.55 0.22 1.24 
2, mj  Standard deviation of average log odds of presence of nodules between geographical areas 0.69 0.31 1.50 
j  Correlation of average log odds of presence of nodules and mf between geographical areas 0.88 0.28 1.00 
specificity One minus the probability of misclassifying a subcutaneous nodule as onchocercal 0.99 0.98 1.00 
a For ease of interpretation, parameter estimates have been transformed to an intuitive scale, where possible (inverse logit 
transformation for intercepts and exponents for other fixed effects parameters). See Appendix A for a detailed description of 
the model and its parameters. 
b Median of posterior distribution. 
c Defined as the 2.5th percentile of the posterior distribution. 
d Defined as the 97.5th percentile of the posterior distribution. 
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Model description 
The current study considers spatially clustered, bivariate binomially distributed data. For analysis of 
spatial data, there are geostatistical techniques that take account of the spatial correlation. These 
techniques require knowledge of the geographical coordinates of the data points, which were not fully 
available in our case. Instead, we used an ordinary hierarchical approach to model the data to account 
for spatial correlation. 
There are several popular alternatives for modeling bivariate binomially distributed data. Multivariate 
probit regression models have been proposed. These models are convenient in terms of 
computational requirements because they only quantify the correlation between observations, leaving 
variance at the lowest level of the data unidentified (but accounted for) [1]. Depending on the 
researcher’s objective, this can be considered an advantage (computationally less demanding) or a 
drawback (part of the model remains unidentified). Another drawback is that the interpretation of probit 
models may be less intuitive to some, if not many researchers. As a concession to these arguments, a 
 2 
reparameterization of the multivariate logistic regression model has been proposed, which like the 
probit model leaves the variance at the lowest level unidentified [1,2]. However, this reparameterized 
logistic model requires a customized sampling algorithm for efficient Markov chain Monte Carlo 
sampling. In our case, we chose for intuitive interpretation, quantification of all variances, and the use 
of the freely available and widely implemented Gibbs sampling algorithm, leading to the choice of 
generalizing the familiar logistic model as described below. 
The multivariate model used in this study is an extension of the hierarchical logistic regression model 
( )( ) jijTijijijijijij nky εεββpi ++== X,,X|logit , where ijpi  is the probability of finding k  cases of the 
binomially distributed outcome y  in n  individuals from the i-th unit in the j-th cluster, conditional on a 
set of observed covariates ijX  and a set of model parameters β . The error terms ijε  and jε  
represent the variation within and between the j clusters of observation, respectively. We extended this 
model to simultaneously predict m binary outcomes, leading to 
( )( ) jijmTijmijmijmijmijmij nky εεββpi ++== X,,X|logit ,,,, , where mij ,pi  is the probability of observing 
k  cases of the m-th outcome (m = 1: presence of microfilariae in the skin; m = 2: presence of nodules 
in adult males) among mn  observed individuals from the i-th unit (village) in the j-th cluster 
(geographical area). Here, the error terms ijε  and jε  each consist of m components representing the 
variation in log odds of each of the m outcomes within and between the j clusters of observations. For 
each observation, there is a set of observed covariates ijX  (bioclime), and for each of the m predicted 
binary outcomes we have a set model parameters mβ . In our case, the intercepts 1,0 =mβ  and 2,0 =mβ  
represent the mean log odds of presence of mf and nodule in the data, respectively. The parameters 
1,1 =mβ  and 2,1 =mβ  represent the log odds ratio of observing presence of microfilariae in the skin and 
subcutaneous onchocercal nodules in a certain bioclime, respectively, relative to a reference bioclime 
(multiple sets of such parameter can be added to stratify the analysis by multiple bioclimes and/or 
other characteristics). Correlation between onchocercal nodule and mf prevalence was modeled by 
assuming multivariate normal (MVN) distributions for the error terms: ( )
ijij
MVNij εεµε Σ,~  and 
( )
jj
MVNj εεµε Σ,~ , with ( )0,0== jij εε µµ . Here, ijεΣ  and jεΣ  are variance-covariance matrices 
with size m x m, containing along the diagonal the marginal variances of the errors for the log odds of 
 3 
presence of nodules and mf within ( 2 1, =mijσ  and 2 2, =mijσ ) and between ( 2 1, =mjσ  and 2 2, =mjσ ) the j 
clusters of observations. The off-diagonal positions of 
ijε
Σ  and 
jε
Σ  hold the covariances 2;1, == mmijσ  
and 2;1, == mmjσ  of error terms within and between the j clusters, respectively. The correlation between 
log odds of presence of nodules and mf at village-level ijρ  was derived by 
2,1,
2;1,
==
==
mijmij
mmij
σσ
σ
. Correlation 
jρ  was derived in a similar fashion, and can be interpreted in two ways; 1) together with variances 
2
1, =mjσ  and 
2
2, =mjσ , jρ  represents how the association between onchocercal nodule and mf 
prevalences varies between geographical regions due to e.g. environmental factors and surveys 
methods (analogous to linear regression models with a random intercept); 2) jρ  is the correlation 
between the mean log odds of presence of nodules and mf in a geographical area (as defined for the 
data in this study). 
Parameter estimation 
Model parameters were estimated assuming non-informative prior distributions. For fixed effects 
parameters mβ , we assumed independent normal prior distributions ( )1000,0mNβ . The village-level 
variance-covariance matrix 
ijε
Σ  was estimated assuming a scaled Wishart prior distribution ( )kRWm ,  
for its inverse 1−Σ
ijε
, where R  is the m x m identity matrix mI , and k  is the number of degrees of 
freedom (set to 3, effectively assuming uniform prior information on ijρ ). To maximize the speed of 
model convergence, the variance-covariance matrix 
jε
Σ  for differences between geographical areas 
was hierarchically centered around fixed effects 
mβ , and was estimated assuming independent 
uniform prior distributions for the correlation ( ( )1,1~ −Ujρ ), and standard deviations 
( ( )10,0~
,
Umjσ  or ( )100,0~, Umjσ ), in line with previous recommendations for estimating 
hyperparameters [3]. The prior distribution for minimum sensitivity of nodule palpation (at low 
endemicity levels) was defined as being uniform between 60% and 100%. The prior distribution for 
specificity of nodule palpation was defined as being uniform between 98% and 100%. 
 4 
Figure A1. Autocorrelation plots of Monte Carlo samples for nine parameters. In this study, 
autocorrelation was initially high for some parameters, indicating that the Gibbs sampling algorithm 
was slow in exploring the posterior distribution of these parameters. Autocorrelation was reduced by 
storing only every 20th Monte Carlo sample and running 200,000 iterations (after discarding an initial 
200,000 iterations for burn-in), for which the results are shown here. After this, autocorrelation of 
Monte Carlo samples was similarly low for all parameters and Markov chains. 
 
 
Model parameters were estimated using four Markov chains with each 400,000 Monte Carlo 
simulations. For each chain, the first 200,000 of the saved simulations were considered as burn-in 
simulations and discarded. Such a number of simulations was necessary as the Gibbs sampler 
explored the joint posterior distribution of parameters slowly, indicated by high autocorrelation of 
Monte Carlo samples. To save storage space, only every 20th Monte Carlo sample was stored, 
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effectively reducing autocorrelation (Figure A1). The effective amount of simulations per parameter 
was 40,000 (sum of four Markov chains). The point estimate for each parameter and prediction were 
taken to be the median of the 40,000 simulations. Ninety five percent Bayesian credible intervals were 
calculated as the 2.5th and 97.5th percentiles of the simulations. 
Model convergence was assessed by checking whether the four Markov chains converged to 
the same posterior distribution for each parameter, based on Gelman and Rubin’s convergence 
diagnostic, the potential scale reduction factor (which should be below 1.1; i.e. a posterior credible 
interval of a parameter estimate should not become more than 10% narrower if more Monte Carlo 
samples were drawn) [4]. Because this diagnostic test requires that starting values for each parameter 
in each Markov Chain are over-dispersed with respect to the true posterior distribution of a parameter, 
we assigned heavily over-dispersed initial values to each of the model parameters in each chain (e.g. 
the initial values 1, 10, 50, and 100 for a parameter with an uninformative normal distribution as prior, 
one value for each Markov chain). In our simulations, the potential scale reduction factor was at or 
below 1.001 for all parameters. Furthermore, we checked that all Markov chains arrived in the joint 
posterior distribution of parameter values, as determined by means of Geweke’s test, which compares 
the distribution of the first 10% and last 50% of the Monte Carlo samples within a chain [5]. We also 
checked that Monte Carlo errors were small, relative to the point estimate of each parameter 
(difference of at least factor 100 – 1000). 
Model application 
Given estimates of 
mβ , ijεΣ , and jεΣ , we estimated the conditional distribution of mf prevalence 
*
2,
*
1, | == mijmij pipi  in a hypothetical village i from an unspecified region j outside the dataset, given an 
estimate of the ‘true’ onchocercal nodule prevalence in adult males, corrected for misclassification of 
nodules, in the same hypothetical village (assuming this is exactly known). Given that we are working 
with multivariate normal distributions, the conditional distribution for * 2,
*
1, | == mijmij pipi  can be described 
as 
( ) ( )( ) ( )








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2
2
*
2,
2,
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1
*
2,
*
1, 1,XlogitX~|logit mijijmTijmijij
mij
mij
m
T
ijmijmij N σρβpiρσ
σβpipi , where 
( )( )2 1,21* 1 1,~ === − mjjmm N σρββ . To include uncertainty about nodule prevalence * 2, =mijpi  in the 
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prediction of mf prevalence * 1, =mijpi , we simulated values from the estimated distribution of 
( )* 2,logit =mijpi , and fed these into the distribution for ( )* 2,* 1, |logit == mijmij pipi , from which values for 
*
1, =mijpi  were then simulated. As this was done while simultaneously estimating the values of model 
parameters by means of Markov Chain Monte Carlo sampling, all uncertainty in the model parameter 
estimates was carried through to the final predictions for mf prevalence in hypothetical villages. 
It should be noted that the procedure described above produces predictions pertaining to 
individual villages only, and therefore will produce predictions containing a great deal of uncertainty. 
The amount of uncertainty would be substantially lower if predictions were made based on larger 
samples of adult males, or when made for the mean prevalence of infection in a group of villages. 
However, a prediction for a mean prevalence would ignore possible heterogeneity in infection 
prevalences between villages, which may lead to overly optimistic estimates when e.g. when 
assessing prospects of elimination (the most highly endemic village will determine the required 
duration of an intervention, not the mean prevalence in a region). Nevertheless, if such predictions are 
made (e.g. for a group of villages with known similar levels of infection), or concerning many villages 
(theoretically an infinite number of villages), the mean mf prevalence is described by 
( )( )2* 2,
2,
1,*
1 XlogitX ==
=
=
=
−+ m
T
ijmijij
mij
mij
m
T
ij βpiρσ
σβ , where * 2, =mijpi  is the mean nodule prevalence in the 
group of villages (including uncertainty related to overall sample size). However, usually the number of 
sampled villages is not very high (<1,000, meaning that the denominator of the standard error of the 
mean is <30, approx. the square root of 1,000), and one should therefore simulate the mf prevalence 
separately for every village, sampling village-level error independently for every village, and sampling 
the region-level error simultaneously for all villages. Then, for every set of many repeated simulations 
(i.e. a set consisting of one simulation for each village), the investigator can calculate the mean or any 
other summary statistic of the level of infection in the group of villages (e.g. range or variance), arriving 
at a distribution for the estimated mean or another summary statistic for mf prevalence in a group of 
villages. 
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Model specification in JAGS 
for (i in 1:N) { 
 # Likelihood of nodule data 
 k.nod[i] ~ dbin(sens.nod.p[i] * p.nod[i] + (1-spec.nod)*(1-p.nod[i]), n.nod[i]) 
 sens.nod.p[i] <- sens.nod + (1-sens.nod)*p.nod[i] 
 logit(p.nod[i]) <- B0[region[i],1] + e.vill[i,1] 
  
 # Likelihood of mf data 
 k.mf[i] ~ dbin(p.mf[i],n.mf[i]) 
 logit(p.mf[i]) <- B0[region[i],2] + e.vill[i,2] 
  
 # Correlation of nodule and mf data with regions 
 e.vill[i,1] <- e.vill.raw[i,1] * xi.nod 
 e.vill[i,2] <- e.vill.raw[i,2] * xi.mf 
 e.vill.raw[i,1:2] ~ dmnorm(Mu,Sigma2.inv.raw) 
} 
 
# Priors for fixed effects 
sens.nod ~ dunif( [some value] ,1.0) # [some value] = 0.6, 0.8, or 1.0 (final model) 
spec.nod ~ dunif(0.98 ,1) 
b0.nod ~ dnorm(0,0.001) 
b0.mf ~ dnorm(0,0.001) 
mbam.nod ~ dnorm(0,0.001) 
mbam.mf ~ dnorm(0,0.001) 
 
# Uniform prior for correlation and marginal standard deviations  
# of hierarchically centered random region effects 
for (j in 1:7) { 
 B0[j,1:2] ~ dmnorm(Mu.region[j,1:2],Sigma2.region.inv) 
 Mu.region[j,1] <- b0.nod + mbam.nod*equals(j,2) 
 Mu.region[j,2] <- b0.mf + mbam.mf*equals(j,2) 
} 
Sigma2.region.inv <- inverse(Sigma2.region) 
Sigma2.region[1,1] <- sigma2.nod.region 
Sigma2.region[2,2] <- sigma2.mf.region 
Sigma2.region[1,2] <- covar.nod.mf.region 
Sigma2.region[2,1] <- covar.nod.mf.region 
covar.nod.mf.region <- rho.region * sigma.nod.region * sigma.mf.region 
sigma2.nod.region <- pow(sigma.nod.region,2) 
sigma2.mf.region <- pow(sigma.mf.region,2) 
sigma.nod.region ~ dunif(0,10) 
sigma.mf.region ~ dunif(0,10) 
rho.region ~ dunif(-1,1) 
 
# Scaled inverse Wishart prior for random village effects 
Sigma2.inv.raw ~ dwish(R,scale) 
xi.nod ~ dunif(0,100) 
xi.mf ~ dunif(0,100)  
Sigma2.raw <- inverse(Sigma2.inv.raw) 
sigma.nod <- pow(Sigma2.raw[1,1],0.5) * xi.nod 
sigma.mf <- pow(Sigma2.raw[2,2],0.5) * xi.mf 
rho <- Sigma2.raw[1,2]/sqrt(Sigma2.raw[1,1]*Sigma2.raw[2,2]) 
 
Sigma2[1,1] <- pow(sigma.nod,2) 
Sigma2[1,2] <- rho * sigma.nod * sigma.mf 
Sigma2[2,1] <- Sigma2[1,2] 
Sigma2[2,2] <- pow(sigma.mf,2) 
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# Predictions for REMO samples 
sigma2.mf.REMO <- (1 - rho^2) * pow(sigma.mf,2) 
sigma2.mf.REMO.region <- (1 - rho.region^2) * sigma2.mf.region 
tau.mf.REMO <- pow(sigma2.mf.REMO,-1) 
tau.mf.REMO.region <- pow(sigma2.mf.REMO.region,-1)  
 
for (k in 1:N.REMO) { 
 # Hypothetical REMO village: nodule prevalence 
 k.nod.REMO[k] ~ dbin(sens.nod.p.REMO[k] * p.nod.REMO[k] +  
(1-spec.nod)*(1-p.nod.REMO[k]),n.nod.REMO[k]) 
 sens.nod.p.REMO[k] <- sens.nod + (1-sens.nod)*p.nod.REMO[k] 
 logit(p.nod.REMO[k]) <- b.nod.REMO[k] 
 b.nod.REMO[k] ~ dnorm(0,0.001) 
  
 # Hypothetical REMO village: mf prevalence (non-mosaic) 
 logit(p.mf.REMO.vill[k]) <- b.mf.REMO.vill[k] 
 b.mf.REMO.vill[k] ~ dnorm(b0.mf.REMO.region[k],tau.mf.REMO) 
 b0.mf.REMO.region[k] <- b0.mf.REMO.intercept[k] + 
(sigma.mf/sigma.nod) * rho * (b.nod.REMO[k] - b0.nod) 
 b0.mf.REMO.intercept[k] ~ dnorm(b0.mf,tau.mf.REMO.region) 
  
 # Hypothetical REMO village: mf prevalence (mosaic) 
 logit(p.mf.REMO.vill.mosaic[k]) <- b.mf.REMO.mosaic.vill[k] 
 b.mf.REMO.mosaic.vill[k] ~ dnorm(b0.mf.REMO.mosaic.region[k],tau.mf.REMO) 
 b0.mf.REMO.mosaic.region[k] <- b0.mf.REMO.mosaic.intercept[k] + 
(sigma.mf/sigma.nod) * rho * (b.nod.REMO[k] - (b0.nod + mbam.nod)) 
 b0.mf.REMO.mosaic.intercept[k] ~ dnorm((b0.mf + mbam.mf),tau.mf.REMO.region) 
} 
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